Leukapheresis Market Product Type, Applications, Competitive Landscape, Upcoming Trends, Industry Share, Dynamics, Top Countries Data

The Leukapheresis Market is expected to reach US$ 133.90 million by 2028 from US$ 74.48 million in 2021; it is estimated to grow at a CAGR of 8.7% from 2021 to 2028.

The growth of the leukapheresis market is primarily attributed to the rising number of voluntary blood donors, rising incidence of hematologic diseases, and the surging elderly population. However, the high cost of leukapheresis obstructs the growth of the market to a certain extent.

Get Exclusive Sample PDF @: https://www.premiummarketinsights.com/sample/TIP00015461?utm_source=OpenPr&utm_medium=10640

Analysis of the Top Market Players:

1. Asahi Kasei Corporation
2. Fresenius SE & Co. KGaA
3. Haemonetics Corporation
4. Terumo Corporation
5. STEMCELL Technologies Inc.
6. HemaCare
7. Macopharma
8. AllCells
9. STEMEXPRESS
10. BioIVT

In this report, the market has been segmented on the basis of:

Product Type (Leukapheresis Devices and Leukapheresis Disposables)
Application (Research Applications and Therapeutic Applications)
End User (Blood Component Providers and Blood Centers, Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, and Hospitals and Transfusion Centers)

Get full Report Description, TOC, Table of Figure, Chart, etc. @: https://www.premiummarketinsights.com/reports-tip/leukapheresis-market

Leukapheresis is a procedure that has white blood cells (leukocytes) involved in the body's immune response are segregated from a blood sample. It is a particular form of apheresis in which an element of blood, such as red blood cells or platelets, is obtained while the remaining blood is restored to circulation. Leukapheresis is often used to reduce very high white blood cell (WBC) counts, such as chronic blood cancers like chronic lymphocytic leukemia (CLL). It can also be completed to obtain white blood cells for later transplant, such as to manage abrupt declines in WBC counts throughout cancer chemotherapy. Another use is as a section of a novel form of immunotherapy, termed chimeric antigen receptor (CAR) T-cell therapy, to help fight leukemia, prostate cancer, and other forms of cancers. Leukapheresis can be completed on the person claiming treatment (autologous apheresis) or on a donor for a later transplant (allogeneic apheresis). Currently, leukapheresis is commonly used to treat various diseases, and it is also used for diagnostic purposes as it can increase circulating tumor cells yields.

Buy this research report at @: https://www.premiummarketinsights.com/buy/TIP00015461?utm_source=OpenPr&utm_medium=10640

Contact Us:
If you have any queries about this report or if you would like further information, please
Contact Person: Ankit Mathur
Phone: +1-646-491-9876
Email: sales@premiummarketinsights.com

About Us:
Premium Market Insights is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost-effective research reports and solutions from various publishers.
The market research industry has changed in last decade. As corporate focus has shifted to niche markets and emerging countries, a number of publishers have stepped in to fulfil these information needs. We have experienced and trained staff that helps you navigate different options and lets you choose best research solution at most effective cost.
Premium Market Insights has an extensive coverage of industry reports, company reports and country reports across all industries. In case your research needs are not met by syndicated reports offered by leading publishers, we can help you by offering a customized research solution by liaising with different research agencies saving your valuable time and money.
We provide best in class customer service and our customer support team is always available to help you on your research queries. Our commitment to customer service is best exemplified by free analyst support that we offer to our clients which sets us apart from any other provider. We also offer enterprise subscriptions which provide significant cost savings to our clients.

This release was published on openPR.